Nuclear factor, erythroid 2-like 2 (NFE2L2) expression is markedly increased in NK cells from patients with severe COVID-19, indicating its role in influencing NK cell activity and antiviral responses, likely reflecting an attempt to mitigate oxidative stress and inflammation (Fig 4B). Here, NFE2L2 is linked to COVID-19.